Glaucoma Market
                     Glaucoma 
Presented by- DelveInsight Business Research

What is Glaucoma Market?
DelveInsight’s Glaucoma Market Insights, Epidemiology, and Market Forecast–2030’ report 
deliver an in-depth understanding of the Glaucoma, historical and forecasted epidemiology as 
well as the Glaucoma market trends in the United States, EU5 (Germany, France, Italy, Spain, 
and the United Kingdom) and Japan. 
The Glaucoma market report provides current treatment practices, emerging drugs, and 
market share of the individual therapies, current and forecasted 7MM Glaucoma market 
size from 2018 to 2030. The Report also covers current Glaucoma treatment practice, 
market drivers, market barriers, SWOT analysis, reimbursement, and market access, and 
unmet medical needs to curate the best of the opportunities and assesses the underlying 
potential of the market.
Open-angle glaucoma (OAG) is the most common form of the disease. The 
drainage angle formed by the cornea and iris remains open, but the trabecular 
meshwork is partially blocked. This causes pressure in the eye to increase 
gradually and damages the optic nerve. It happens so slowly that the patient may 
lose vision before they are even aware of a problem, while in the case of narrow-
angle glaucoma, the structure inside the eye that allows fluid to drain normally 
from the eye (called the drainage angle) becomes restricted. Narrow drainage 
angles in the eye increase the risk of the drainage angle that gets blocked, 
resulting in a significant increase in eye pressure and risk of vision loss. If this 
occurs, narrow-angle glaucoma is usually called angle-closure glaucoma. 
How Many Regions Are 
Covered?
● The US
● EU5 (Germany, France, Italy, Spain, 
and the United Kingdom)
● Japan
What are the major types of 
Glaucoma? 
There are two major types of 
glaucoma, i.e., Primary open-angle 
glaucoma (POAG), and Angle-closure 
/glaucoma closed-angle 
glaucoma/narrow-angle glaucoma. 
The “angle” in both cases refers to 
the drainage angle inside the eye 
that controls the outflow of the 
watery fluid (aqueous) which is 
being produced inside the eye. 
Glaucoma Emerging
 Drugs 
• PDP-716: Sun Pharma Advanced Research Company Limited (SPARC)
• PRO-122: Laboratorios Sophia S.A de C.V.
What is the Glaucoma Market Report 
Scope?
● The report covers the descriptive overview of Glaucoma, explaining its causes, symptoms, 
pathophysiology, genetic basis, and currently available therapies.
● Comprehensive insight has been provided into the Glaucoma epidemiology and treatment.
● Additionally, an all-inclusive account of both the current and emerging therapies for Glaucoma is 
provided, along with the assessment of new therapies, which will have an impact on the current 
treatment landscape.
● A detailed review of the Glaucoma market; historical and forecasted is included in the report, 
covering the 7MM drug outreach.
● The report provides an edge while developing business strategies, by understanding trends 
shaping and driving the 7MM Glaucoma market
What are the Glaucoma Market
Report Highlights?
● The robust pipeline with novel MOA and oral ROA, increasing prevalence, effectiveness of drugs 
as both mono and combination therapy will positively drive the Glaucoma market.
● The companies and academics are working to assess challenges and seek opportunities that 
could influence Glaucoma R&D. The therapies under development are focused on novel 
approaches to treat/improve the disease condition.
● Major players are involved in developing therapies for Glaucoma. The launch of emerging 
therapies will significantly impact the Glaucoma market.
● Our in-depth analysis of the pipeline assets across different stages of development (Phase III and 
Phase II), different emerging trends and comparative analysis of pipeline products with detailed 
clinical profiles, key cross-competition, launch date along with product development activities 
will support the clients in the decision-making process regarding their therapeutic portfolio by 
identifying the overall scenario of the research and development activities.
[email protected]
[email protected]
+91-9650213330
CREDITS: This presentation template was 
created by Slidesgo, including icons by 
DFola tYiconu,  aHnda invfoeg rAapnhiycs  Q& uimeagsetsi obyn  or 
Freepik
Query?
Please keep this slide for attribution
Than
CREDITS: This presentation template was 
created by Slidesgo, including icons by 
Flaticon, and infographics & images by 
kFresepik !